New test offers clarity for couples struggling to conceive

A new male fertility test based on Cornell research could help predict which men might need treatment and which couples might have success with different forms of assisted reproduction.

Pandemic injects new urgency into coronavirus collaborations

Susan Daniel and Gary Whittaker discuss their collaborations and others across Cornell’s campuses that are working to better understand the COVID-19 virus.

Ezra

Cornell Atkinson awards $1.1M to innovative projects

Cornell Atkinson has awarded seven Academic Venture Fund seed grants, totaling $1.1 million, for projects that engage faculty from eight Cornell colleges and 16 academic departments.

Electrochemical reaction powers new drug discoveries

A Cornell-led collaboration is flipping the switch on traditional synthetic chemistry by using electricity to drive a new chemical reaction that previously stumped chemists.

Neurons thrive even when malnourished

When embryos and fetuses undergo malnutrition, their developing nervous systems get preferential use of any available nutrients. Now, new research shows that a stressor gene called FoxO helps control the nervous system's growth.

Big Red data: crunching numbers to fight COVID-19 and more

Cornell data scientists are developing models and mathematical techniques to address the world’s most vexing problems, from public health crises to climate change.

National tick surveillance survey identifies gaps to be filled

New Cornell-led research shows that inadequate funding is the main barrier to better surveillance and control of ticks, including the blacklegged tick, which spreads Lyme disease, the No. 1 vector-borne illness in the country.

(Virtual) Things to Do, June 12-26, 2020

Virtual events at Cornell include a Russian conversation series; trainings on racism and allyship; a Congressional Black Caucus panel; a COVID-19 bereavement support group and live Alliance for Science talks.

Expanding precision medicine’s potential for humans, dogs

Researchers from Weill Cornell Medicine and the College of Veterinary Medicine are expanding the potential of precision medicine for canine and human patients, by studying a lymphoma that occurs in both people and dogs.